Human immunodeficiency virus type 1 incidence among blood donors in France, 1992 through 2006: Use of an immunoassay to identify recent infections

Transfusion

Volumn 48, Issue 8, 2008, Pages 1567-1575

  Pillonel, Josiane ^a   Barin, Francis ^b   Laperche, Syria ^b   Bernillon, Pascale ^b   Le Vu, Stéphane ^b   Brunet, Sylvie ^b   Thierry, Damien ^b   Desenclos, Jean Claude ^b  

^a INSTITUT DE VEILLE SANITAIRE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; FRANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BLOOD DONORS; COHORT STUDIES; FEMALE; FRANCE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOENZYME TECHNIQUES; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; SEX DISTRIBUTION;

EID: 48249141102     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01739.x     Document Type: Article

References (30)

1. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996 334 : 1685 90.
2. Glynn SA, Kleinman SH, Wright DJ, Busch MP. International application of the incidence rate/window period model. Transfusion 2002 42 : 966 72.
3. Pillonel J, Laperche S, Saura C, Desenclos JC, Courouce AM. Trends in residual risk of transfusion-transmitted viral infections in France between 1992 and 2000. Transfusion 2002 42 : 980 8.
4. Pillonel J, Laperche S. Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT). Euro Surveill 2005 10 : 5 8.
5. Lackritz EM, Satten GA, Aberle-Grasse J, Dodd RY, Raimondi VP, Janssen RS, Lewis WF, Notari EP, Petersen LR. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 1995 333 : 1721 5.
6. Soldan K, Barbara JA, Ramsay ME, Hall AJ. Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001. Vox Sang 2003 84 : 274 86.
7. Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, Hecht FM, Jack N, Cleghorn FR, Kahn JO, Chesney MA, Busch MP. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998 280 : 42 8.
8. Barin F, Meyer L, Lancar R, Deveau C, Gharib M, Laporte A, Desenclos JC, Costagliola D. Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots. J Clin Microbiol 2005 43 : 4441 7.
9. Barin F, Courouce AM, Pillonel J, Buzelay L. Increasing diversity of HIV-1M serotypes in French blood donors over a 10-year period (1985-1995). Retrovirus Study Group of the French Society of Blood Transfusion. AIDS 1997 11 : 1503 8.
10. Pillonel J, Le Marrec N, Giraud A, David D, Laperche S. Epidemiological surveillance of blood donors and residual risk of blood-borne infections in France, 2001 to 2003. Transfus Clin Biol 2005 12 : 239 46.
11. Semaille C, Barin F, Cazein F, Pillonel J, Lot F, Brand D, Plantier JC, Bernillon P, Le VS, Pinget R, Desenclos JC. Monitoring the dynamics of the HIV epidemic using assays for recent infection and serotyping among new HIV diagnoses: experience after 2 years in France. J Infect Dis 2007 196 : 377 83.
12. Hosmer DW, Lemershow S. Applied logistic regression. New York : John Wiley & Sons 1989.
13. Fleiss J. Statistical methods for rates and proportions. 2nd ed. New York : John Wiley 1981.
14. Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, Pappalardo B, Kleinman SH. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005 45 : 254 64.
15. Sakarovitch C, Rouet F, Murphy G, Minga AK, Alioum A, Dabis F, Costagliola D, Salamon R, Parry JV, Barin F. Do tests devised to detect recent HIV-1 infection provide reliable estimates of incidence in Africa? J Acquir Immune Defic Syndr 2007 45 : 115 22.
16. Parekh BS, Kennedy MS, Dobbs T, Pau CP, Byers R, Green T, Hu DJ, Vanichseni S, Young NL, Choopanya K, Mastro TD, McDougal JS. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses 2002 18 : 295 307.
17. Kothe D, Byers RH, Caudill SP, Satten GA, Janssen RS, Hannon WH, Mei JV. Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. J Acquir Immune Defic Syndr 2003 33 : 625 34.
18. Suligoi B, Massi M, Galli C, Di Sciandra MS, Pezzotti P, Recchia O, Montella F, Sinicco A, Rezza G. Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay. J Acquir Immune Defic Syndr 2003 32 : 424 8.
19. Dodd RY, Notari EP, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002 42 : 975 9.
20. Stramer SL, Glynn SA, Kleinman SH, Strong DM, Sally C, Wright DJ, Dodd RY, Busch MP. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 2004 351 : 760 8.
21. Satten GA, Janssen R, Busch MP, Datta S. Validating marker-based incidence estimates in repeatedly screened populations. Biometrics 1999 55 : 1224 7.
22. Lawson-Ayayi S, Salmi LR. Epidemiology of blood collection in France. Eur J Epidemiol 1999 15 : 285 92.
23. Couturier E, Damond F, Roques P, Fleury H, Barin F, Brunet JB, Brun-Vezinet F, Simon F. HIV-1 diversity in France, 1996-1998. The AC 11 laboratory network. AIDS 2000 14 : 289 96.
24. Pillonel J, Laperche S, et le comité de pilotage. Surveillance épidémiologique des donneurs de sang homologues en France entre 1992 et 2002. 2004 Sep. 1-100 p.
25. Offergeld R, Faensen D, Ritter S, Hamouda O. Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing. Euro Surveill 2005 10 : 8 11.
26. Velati C, Fomiatti L, Baruffi L, Romano L, Zanetti A. Impact of nucleic acid amplification technology (NAT) in Italy in the three years following implementation (2001-2003). Euro Surveill 2005 10 : 12 4.
27. Soldan K, Davison K, Dow B. Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003. Euro Surveill 2005 10 : 17 9.
28. Niederhauser C, Schneider P, Fopp M, Ruefer A, Levy G. Incidence of viral markers and evaluation of the estimated risk in the Swiss blood donor population from 1996 to 2003. Euro Surveill 2005 10 : 14 6.
29. Alvarez do BM, Gonzalez DR, Hernandez SJ, Oyonarte GS. Residual risk of transfusion-transmitted viral infections in Spain, 1997-2002, and impact of nucleic acid testing. Euro Surveill 2005 10 : 22 4.
30. O'Brien SF, Yi QL, Fan W, Scalia V, Kleinman SH, Vamvakas EC. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services. Transfusion 2007 47 : 316 25.